Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19687336

Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Sep 20
First author
Sparano JA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Mar 10;28(8):e128; author reply e129-30. doi: 10.1200/JCO.2009.26.8243.
    note
    Source null
    related pmid
    20100949
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2010 Apr 20;28(12):e193-4; author reply e195-6. doi: 10.1200/JCO.2009.26.8052.
    note
    Source null
    related pmid
    20194839
    relationship
    Comment in

Authors and identifiers

  1. name
    Sparano JA
    type
    Author
  2. name
    Makhson AN
    type
    Author
  3. name
    Semiglazov VF
    type
    Author
  4. name
    Tjulandin SA
    type
    Author
  5. name
    Balashova OI
    type
    Author
  6. name
    Bondarenko IN
    type
    Author
  7. name
    Bogdanova NV
    type
    Author
  8. name
    Manikhas GM
    type
    Author
  9. name
    Oliynychenko GP
    type
    Author
  10. name
    Chatikhine VA
    type
    Author
  11. name
    Zhuang SH
    type
    Author
  12. name
    Xiu L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sparano JA
    type
    Author
  2. name
    Makhson AN
    type
    Author
  3. name
    Semiglazov VF
    type
    Author
  4. name
    Tjulandin SA
    type
    Author
  5. name
    Balashova OI
    type
    Author
  6. name
    Bondarenko IN
    type
    Author
  7. name
    Bogdanova NV
    type
    Author
  8. name
    Manikhas GM
    type
    Author
  9. name
    Oliynychenko GP
    type
    Author
  10. name
    Chatikhine VA
    type
    Author
  11. name
    Zhuang SH
    type
    Author
  12. name
    Xiu L
    type
    Author
bibliography ids
  1. nci-bib-67a63c9c51256104be76cd23
book metadata
content sha256
01704ba05b8d690caad9715e16ddfb8062b2be26645723bda65b1fbf2da84865
document type
citation
dois
  1. 10.1200/JCO.2008.20.5013
electronic publication date
display
2009 Aug 17
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19687336
immutable id
pubmed:19687336@01704ba05b8d690caad9715e16ddfb8062b2be26645723bda65b1fbf2da84865
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
27
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4522-9
volume
27
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Mar 10;28(8):e128; author reply e129-30. doi: 10.1200/JCO.2009.26.8243.
    note
    Source null
    related pmid
    20100949
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2010 Apr 20;28(12):e193-4; author reply e195-6. doi: 10.1200/JCO.2009.26.8052.
    note
    Source null
    related pmid
    20194839
    relationship
    Comment in
outcomes validated
false
pmid
19687336
provenance
batch id
0706b5111d1451f52f74
provider
NCBI PubMed ESummary
record sha256
4e32b194542e7d38112357250db94b4298bb2c442d631f256d3bd53fabdb31ce
response sha256
98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
retrieved at
2026-09-09T23:46:29.215195+00:00
publication date
display
2009 Sep 20
precision
day
year
2009
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19687336/
title
Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.

Preserved source evidence · Not medical advice